Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Serotonin function following remission from bulimia nervosa.

Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC.

Neuropsychopharmacology. 2000 Mar;22(3):257-63.

2.

Decreased serotonin function in bulimia nervosa.

Jimerson DC, Wolfe BE, Metzger ED, Finkelstein DM, Cooper TB, Levine JM.

Arch Gen Psychiatry. 1997 Jun;54(6):529-34.

PMID:
9193193
3.
4.

Psychological, hormonal and biochemical changes following carbohydrate bingeing: a placebo controlled study in bulimia nervosa and matched controls.

Turner MS, Foggo M, Bennie J, Carroll S, Dick H, Goodwin GM.

Psychol Med. 1991 Feb;21(1):123-33.

PMID:
2047488
5.
6.

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.

Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC.

Arch Gen Psychiatry. 1992 Nov;49(11):852-61.

PMID:
1444722
7.

Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.

Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM.

Arch Gen Psychiatry. 1997 Jun;54(6):521-7.

PMID:
9193192
8.

Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges.

Buydens-Branchey L, Branchey M, Hudson J, Rothman M, Fergeson P, McKernin C.

Biol Psychiatry. 1999 May 15;45(10):1300-6.

PMID:
10349036
9.

Research update on serotonin function in bulimia nervosa and anorexia nervosa.

Wolfe BE, Metzger E, Jimerson DC.

Psychopharmacol Bull. 1997;33(3):345-54. Review.

PMID:
9550877
10.

Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa.

Ward A, Brown N, Lightman S, Campbell IC, Treasure J.

Br J Psychiatry. 1998 Apr;172:351-8.

PMID:
9715339
11.

Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.

Williamson DJ, McTavish SF, Park SB, Cowen PJ.

Br J Psychiatry. 1995 Aug;167(2):238-42.

PMID:
7582676
12.

Studies of serotonin function in anorexia nervosa.

Brewerton TD, Jimerson DC.

Psychiatry Res. 1996 Apr 16;62(1):31-42.

PMID:
8739113
13.

Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa.

Weltzin TE, Fernstrom MH, Fernstrom JD, Neuberger SK, Kaye WH.

Am J Psychiatry. 1995 Nov;152(11):1668-71.

PMID:
7485633
14.

The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa.

Goldbloom DS, Garfinkel PE, Katz R, Brown GM.

J Psychosom Res. 1996 Mar;40(3):289-97.

PMID:
8861125
15.

Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.

Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.

Arch Gen Psychiatry. 1992 Jan;49(1):21-8.

PMID:
1728249
16.

A placebo-controlled trial of d-fenfluramine in bulimia nervosa.

Fahy TA, Eisler I, Russell GF.

Br J Psychiatry. 1993 May;162:597-603.

PMID:
8149110
17.

Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.

Monteleone P, Brambilla F, Bortolotti F, Ferraro C, Maj M.

Psychol Med. 1998 Jul;28(4):975-83.

PMID:
9723152
18.

Symptomatic relapse in bulimia nervosa following acute tryptophan depletion.

Smith KA, Fairburn CG, Cowen PJ.

Arch Gen Psychiatry. 1999 Feb;56(2):171-6.

PMID:
10025442
19.

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ.

Arch Gen Psychiatry. 1998 Oct;55(10):927-35.

PMID:
9783564
20.

Supplemental Content

Support Center